Effects of dual antiplatelet therapy de-escalation on the prognosis of acute coronary syndrome patients at high risk of ischemia who underwent percutaneous coronary intervention

被引：0
|
作者：
Wang, Jingyao [1 ]
Li, Yachao [1 ]
Lei, Mengjie [1 ]
Yang, Yanli [1 ]
Gao, Haiyan [1 ]
Wang, Xiangjin [1 ]
An, Lei [1 ]
Zhou, Haili [1 ]
Sun, Xue [1 ]
Li, Cairong [1 ]
Zhao, Zhigang [1 ]
Xue, Zengming [1 ]
机构：
[1] Hebei Med Univ, Langfang Peoples Hosp, Dept Cardiol, Langfang Core Lab Precis Treatment Coronary Artery, 37 Xinhua Rd, Langfang 065000, Hebei, Peoples R China
来源：
CHINESE MEDICAL JOURNAL | 2024年 / 137卷 / 06期
关键词：
ACUTE MYOCARDIAL-INFARCTION; CLOPIDOGREL; TICAGRELOR;
D O I：
10.1097/CM9.0000000000003011
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：746 / 748
页数：3
相关论文
共 50 条
  • [31] Real-World Analyses of the De-Escalation of Dual Antiplatelet Therapy in Treatment of Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention in Taiwan
    Li, Yi-Heng
    Hsieh, I. -Chang
    Lin, Hui-Wen
    Lin, Sheng-Hsiang
    ACTA CARDIOLOGICA SINICA, 2025, 41 (01) : 106 - 120
  • [32] AGE AND OUTCOMES FOLLOWING GUIDED DE-ESCALATION OF ANTIPLATELET TREATMENT IN ACUTE CORONARY SYNDROME PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: RESULTS OF A RANDOMIZED MULTICENTRE TRIAL
    Sibbing, Dirk
    Gross, Lisa
    Trenk, Dietmar
    Jacobshagen, Claudius
    Geisler, Tobias
    Hadamitzky, Martin
    Merkely, Bela
    Kiss, Robert
    Komocsi, Andras
    Parma, Radoslaw
    Gori, Tommaso
    Felix, Stephan
    Schwinger, Robert
    Neumann, Franz-Josef
    Hausleiter, Joerg
    Baylacher, Monika
    Koltowski, Lukasz
    Mehilli, Julinda
    Huber, Kurt
    Huczek, Zenon
    Aradi, Daniel
    Massberg, Steffen
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1203 - 1203
  • [33] Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention
    Bagai, Akshay
    Bhatt, Deepak L.
    Eikelboom, John W.
    Mancini, G. B. John
    Cohen, Eric A.
    Vijayaraghavan, Ram
    Cheema, Asim N.
    Udell, Jacob A.
    Niznick, Joel
    Tanguay, Jean-Francois
    Verma, Subodh
    Mehta, Shamir R.
    CIRCULATION, 2016, 133 (21) : 2094 - 2098
  • [34] Optimal duration of dual antiplatelet therapy post percutaneous coronary intervention in acute coronary syndrome
    Deharo, Pierre
    Cuisset, Thomas
    TRENDS IN CARDIOVASCULAR MEDICINE, 2020, 30 (04) : 198 - 202
  • [35] Efficacy and Safety of Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients
    Han, Jialun
    Zhang, Yi
    Shi, Xiujin
    Lin, Baidi
    Zhang, Yunnan
    Zhang, Ru
    Wang, Yifan
    Yan, Jialin
    Lin, Yang
    GLOBAL HEART, 2023, 18 (01)
  • [36] TRIPLE VERSUS DUAL ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION
    Hubin
    Zhouyujie
    Liuyuyang
    Shidongmei
    Zhaoyingxin
    Jiadean
    HEART, 2011, 97
  • [37] Optimizing antiplatelet therapy in acute coronary syndrome and percutaneous coronary intervention
    Faxon, David P.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2012, 79 (02) : 181 - 197
  • [38] Antiplatelet Therapy for Elderly Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Fioretti, Vincenzo
    Sperandeo, Luca
    Gerardi, Donato
    Di Fazio, Aldo
    Stabile, Eugenio
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (14)
  • [39] The comparison of short-term dual antiplatelet therapy versus standard dual antiplatelet therapy in elderly patients with coronary artery disease who underwent percutaneous coronary intervention
    Jin, I.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [40] De-escalation of anti-platelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a narrative review
    Han Ya-Ling
    中华医学杂志英文版, 2019, 132 (02) : 197 - 210
12345